-
Baloxavir Marboxil 1985606-14-1
API’s Name Indication Innovator Patent Expiry Date(The U.S) Baloxavir Marboxil 1985606-14-1 Influenza Shionogi & Roche Sep.21,2031 -
Agomelatine
API’s Name Indication Specification US DMF EU DMF CEP Agomelatine Depression In-House √ -
Atorvastatin Calcium
API’s Name Indication Specification US DMF EU DMF CEP Atorvastatin Calcium Hypercholesterolemia In-House/CEP 29057 √ CEP 2015-034